High skin lesions, low fever new symptoms of monkeypox: Lancet

High skin lesions, low fever new symptoms of monkeypox: Lancet The researchers also predict that the high prevalence of genital skin lesions in patients and the high rate of co-occurring sexually transmitted infections means that sexual health clinics are likely to see additional monkeypox cases in the future. https://ift.tt/bpcTR7U

Diabetes, BP medicines to get cheaper by month-end

Diabetes, BP medicines to get cheaper by month-end The biggest reduction in price came in case of formulations based on Sitagliptin Phosphate — an anti-diabetic medicine used to treat type II diabetes. A strip of 10 Sitagliptin Phosphate Monohydrate tablets from a reputable brand is now being sold at Rs 347. https://ift.tt/9tCJ7se

3 new BA.2 variants found, may have role in ongoing surge: Experts

3 new BA.2 variants found, may have role in ongoing surge: Experts Three new and highly transmissible "offspring" of Omicron's BA.2 subvariant have been detected in India. https://ift.tt/9tCJ7se

2 Delhi CGHS doctors suspended for favouring pharma company

2 Delhi CGHS doctors suspended for favouring pharma company The minister ordered an enquiry and the preliminary probe revealed severe violations in prescribing medicines and that a group of doctors were favouring a particular pharmaceutical company, an official source said on Sunday. https://ift.tt/9tCJ7se

CoWIN is tech backbone of India's vaccination drive: Govt

CoWIN is tech backbone of India's vaccination drive: Govt Dr RS Sharma, CEO NHA while giving the keynote address highlighted upon the role played by the doctors in India's fight against the pandemic and the roll out of the vaccination drive. https://ift.tt/9tCJ7se

Active COVID-19 cases in country rise to 1,11,711

Active COVID-19 cases in country rise to 1,11,711 The active cases comprise 0.26 per cent of the total infections, while the national COVID-19 recovery rate was recorded at 98.54 per cent, the ministry said. https://ift.tt/9tCJ7se

Novavax expects COVID vaccine targeting Omicron in fourth quarter

Novavax expects COVID vaccine targeting Omicron in fourth quarter The U.S. FDA on Thursday recommended COVID-19 vaccine manufacturers change the design of their booster shots beginning this fall to include components tailored to combat the currently dominant Omicron BA.4 and BA.5 subvariants. https://ift.tt/pgTSaEk